title: Immune thrombocytopenia successfully treated with eltrombopag following multiple therapies including romiplostim.
authors.affiliation: Transfusion Service, Haemophilia Centre and Haematology Department, Castelfranco Veneto Hospital, Castelfranco Veneto, Italy.
authors.forename: Roberto
authors.initials: R
authors.lastname: Sartori
authors.affiliation: Transfusion Service, Haemophilia Centre and Haematology Department, Castelfranco Veneto Hospital, Castelfranco Veneto, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: Candiotto
authors.affiliation: Department of Cell Therapy and Haematology, San Bortolo Hospital, Vicenza, Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Ruggeri
authors.affiliation: Transfusion Service, Haemophilia Centre and Haematology Department, Castelfranco Veneto Hospital, Castelfranco Veneto, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Tagariello
mesh_terms: D001565:Benzoates / Q000627:therapeutic use*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008297:Male; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D011720:Pyrazoles / Q000627:therapeutic use*; D011961:Receptors, Fc / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D013926:Thrombopoietin / Q000627:therapeutic use*
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag